Aprea Therapeutics, Inc. Employee Benefit and Share-based Payment Arrangement, Noncash
Aprea Therapeutics, Inc. (APRE) reported Employee Benefit and Share-based Payment Arrangement, Noncash of $204.26 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:EmployeeBenefitsAndShareBasedCompensationNoncash · last filed 2026-08-12
- Aprea Therapeutics, Inc. employee benefit and share-based payment arrangement, noncash for the quarter ending 2026-06-30 was $103.19K, a 24.53% decline year-over-year.
- Aprea Therapeutics, Inc. employee benefit and share-based payment arrangement, noncash for the quarter ending 2026-03-31 was $101.07K, a 14.81% decline year-over-year.
- Aprea Therapeutics, Inc. employee benefit and share-based payment arrangement, noncash for the quarter ending 2025-12-31 was $109.02K, a 13.49% decline year-over-year.
- Aprea Therapeutics, Inc. employee benefit and share-based payment arrangement, noncash for the quarter ending 2025-09-30 was $113.75K, a 23.70% decline year-over-year.
- Aprea Therapeutics, Inc. employee benefit and share-based payment arrangement, noncash for fiscal 2025 was $478.14K, a 2.31% decline from fiscal 2024.
- Aprea Therapeutics, Inc. employee benefit and share-based payment arrangement, noncash for fiscal 2024 was $489.44K, a 10.12% increase from fiscal 2023.
- Aprea Therapeutics, Inc. employee benefit and share-based payment arrangement, noncash for fiscal 2023 was $444.46K, a 97.38% decline from fiscal 2022.
- Aprea Therapeutics, Inc. employee benefit and share-based payment arrangement, noncash for fiscal 2022 was $16.98M, a 117.33% increase from fiscal 2021.
| Period end | Employee Benefit and Share-based Payment Arrangement, Noncash 3 month | Employee Benefit and Share-based Payment Arrangement, Noncash 6 month | Employee Benefit and Share-based Payment Arrangement, Noncash 9 month | Employee Benefit and Share-based Payment Arrangement, Noncash 12 month |
|---|---|---|---|---|
| 2026-06-30 | $103.19K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $204.26K 10-Q · filed 2026-08-12 | $313.29K derived: sum of 3 quarters · filed 2026-08-12 | $427.04K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $101.07K 10-Q · filed 2026-05-13 | $210.09K derived: sum of 2 quarters · filed 2026-05-13 | $323.85K derived: sum of 3 quarters · filed 2026-05-13 | $460.57K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $109.02K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $222.78K derived: sum of 2 quarters · filed 2026-03-16 | $359.51K derived: sum of 3 quarters · filed 2026-08-12 | $478.14K 10-K · filed 2026-03-16 |
| 2025-09-30 | $113.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $250.48K derived: sum of 2 quarters · filed 2026-08-12 | $369.12K 10-Q · filed 2025-11-12 | $495.14K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $136.73K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $255.36K 10-Q · filed 2026-08-12 | $381.39K derived: sum of 3 quarters · filed 2026-08-12 | $530.48K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $118.63K 10-Q · filed 2026-05-13 | $244.66K derived: sum of 2 quarters · filed 2026-05-13 | $393.75K derived: sum of 3 quarters · filed 2026-05-13 | $522.24K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $126.03K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $275.12K derived: sum of 2 quarters · filed 2026-03-16 | $403.61K derived: sum of 3 quarters · filed 2026-03-16 | $489.44K 10-K · filed 2026-03-16 |
| 2024-09-30 | $149.09K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $277.58K derived: sum of 2 quarters · filed 2025-11-12 | $363.41K 10-Q · filed 2025-11-12 | $446.27K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $128.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $214.32K 10-Q · filed 2025-08-12 | $297.18K derived: sum of 3 quarters · filed 2025-08-12 | $373.21K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $85.83K 10-Q · filed 2025-05-14 | $168.69K derived: sum of 2 quarters · filed 2025-05-14 | $244.72K derived: sum of 3 quarters · filed 2025-05-14 | $514.04K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $82.86K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | $158.89K derived: sum of 2 quarters · filed 2025-03-25 | $428.21K derived: sum of 3 quarters · filed 2025-03-25 | $444.46K 10-K · filed 2025-03-25 |
| 2023-09-30 | $76.03K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $345.35K derived: sum of 2 quarters · filed 2024-11-07 | $361.60K 10-Q · filed 2024-11-07 | $418.95K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $269.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $285.57K 10-Q · filed 2024-08-12 | $342.92K derived: sum of 3 quarters · filed 2024-08-12 | $381.16K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $16.24K 10-Q · filed 2024-05-14 | $73.60K derived: sum of 2 quarters · filed 2024-05-14 | $111.83K derived: sum of 3 quarters · filed 2024-05-14 | $14.91M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $57.35K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | $95.59K derived: sum of 2 quarters · filed 2024-03-26 | $14.90M derived: sum of 3 quarters · filed 2024-03-26 | $16.98M 10-K · filed 2024-03-26 |
| 2022-09-30 | $38.24K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $14.84M derived: sum of 2 quarters · filed 2023-11-09 | $16.92M 10-Q · filed 2023-11-09 | $19.02M derived: sum of 4 quarters · filed 2024-03-26 |
| 2022-06-30 | $14.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $16.89M 10-Q · filed 2023-08-10 | $18.98M derived: sum of 3 quarters · filed 2024-03-26 | $21.01M derived: sum of 4 quarters · filed 2024-03-26 |
| 2022-03-31 | $2.08M 10-Q · filed 2023-05-15 | $4.18M derived: sum of 2 quarters · filed 2024-03-26 | $6.21M derived: sum of 3 quarters · filed 2024-03-26 | $8.08M derived: sum of 4 quarters · filed 2024-03-26 |
| 2021-12-31 | $2.09M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | $4.13M derived: sum of 2 quarters · filed 2024-03-26 | $5.99M derived: sum of 3 quarters · filed 2024-03-26 | $7.81M 10-K · filed 2024-03-26 |
| 2021-09-30 | $2.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $3.90M derived: sum of 2 quarters · filed 2022-11-09 | $5.72M 10-Q · filed 2022-11-09 | $7.15M derived: sum of 4 quarters · filed 2023-03-30 |
| 2021-06-30 | $1.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $3.69M 10-Q · filed 2022-08-12 | $5.12M derived: sum of 3 quarters · filed 2023-03-30 | $6.51M derived: sum of 4 quarters · filed 2023-03-30 |
| 2021-03-31 | $1.82M 10-Q · filed 2022-05-16 | $3.25M derived: sum of 2 quarters · filed 2023-03-30 | $4.64M derived: sum of 3 quarters · filed 2023-03-30 | $5.90M derived: sum of 4 quarters · filed 2023-03-30 |
| 2020-12-31 | $1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $2.82M derived: sum of 2 quarters · filed 2023-03-30 | $4.08M derived: sum of 3 quarters · filed 2023-03-30 | $4.98M 10-K · filed 2023-03-30 |
| 2020-09-30 | $1.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $2.65M derived: sum of 2 quarters · filed 2021-11-08 | $3.55M 10-Q · filed 2021-11-08 | $4.37M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-06-30 | $1.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $2.16M 10-Q · filed 2021-08-12 | $2.98M derived: sum of 3 quarters · filed 2022-03-15 | $3.22M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-03-31 | $905.47K 10-Q · filed 2021-05-06 | $1.72M derived: sum of 2 quarters · filed 2022-03-15 | $1.97M derived: sum of 3 quarters · filed 2022-03-15 | $2.15M derived: sum of 4 quarters · filed 2022-03-15 |
| 2019-12-31 | $814.59K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $1.06M derived: sum of 2 quarters · filed 2022-03-15 | $1.25M derived: sum of 3 quarters · filed 2022-03-15 | $1.35M 10-K · filed 2022-03-15 |
| 2019-09-30 | $246.22K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $433.19K derived: sum of 2 quarters · filed 2020-11-06 | $531.13K 10-Q · filed 2020-11-06 | $610.67K derived: sum of 4 quarters · filed 2021-03-16 |
| 2019-06-30 | $186.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $284.91K 10-Q · filed 2020-08-11 | $364.45K derived: sum of 3 quarters · filed 2021-03-16 | |
| 2019-03-31 | $97.95K 10-Q · filed 2020-05-15 | $177.49K derived: sum of 2 quarters · filed 2021-03-16 | ||
| 2018-12-31 | $79.54K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $329.18K 10-K · filed 2021-03-16 | ||
| 2018-09-30 | $249.65K 10-Q · filed 2019-11-14 | |||
| 2017-12-31 | $395.44K 10-K · filed 2020-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |